$2.3 - PROK | ProKidney Corp. Class A Ordinary Shares

ProKidney Corp. Class A Ordinary Shares (PROK)

ProKidney Corp. Class A Ordinary Shares

XNAS:PROK

2.3

3.60%

Ask

$22.22 - 25.00

Bid

$2.09 - 1.00

Low

$2.13

High

$2.29

Open

$2.2

Prev Close

$2.22

52W High

7.13

52W Low

0.46

Volume

1136983

Avg Vol (3m)

1237914.3

Float

103329407

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Biotechnology

Date Listed: 07/12/2022

Primary Exchange: XNAS

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Phone: 336-999-7028

Address: 2000 Frontis Plaza Blvd.

Address 2: Suite 250

City: Winston-salem

State: NC

Postal Code: 27103

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

204

P/E (TTM)

-4.150000

P/B (TTM)

-0.304900

EPS

-0.12

Round Lot

100

Composit FIGI

BBG0119BQ2Y2

Share Class FIGI

BBG0119BQ3S7

Share Class Shares Outstanding

134.99M

Weighted Shares Outstanding

135.98M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion